These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 3479025)

  • 1. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
    Elger W; Fähnrich M; Beier S; Qing SS; Chwalisz K
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1065-74. PubMed ID: 3479025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanisms of action of progesterone antagonists.
    Elger W; Beier S; Chwalisz K; Fähnrich M; Hasan SH; Henderson D; Neef G; Rohde R
    J Steroid Biochem; 1986 Nov; 25(5B):835-45. PubMed ID: 3543502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery.
    Chwalisz K
    Hum Reprod; 1994 Jun; 9 Suppl 1():131-61. PubMed ID: 7962460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of action of antifertile PG in animal models.
    Elger W; Hasan SG
    Acta Physiol Hung; 1985; 65(4):415-32. PubMed ID: 3859989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M; Van Look PF
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
    Bygdeman M; Swahn ML
    Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of endometrial cell biology using progesterone antagonists to manipulate the implantation window.
    Beier HM; Hegele-Hartung C; Mootz U; Beier-Hellwig K
    Hum Reprod; 1994 Jun; 9 Suppl 1():98-115. PubMed ID: 7962476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of onapristone on uterine prostaglandin production and plasma progesterone concentrations in guinea-pigs during early and mid-pregnancy.
    Poyser NL
    J Reprod Fertil; 1993 Nov; 99(2):665-72. PubMed ID: 8107052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Gottlieb C
    Hum Reprod; 1994 Jun; 9 Suppl 1():121-5. PubMed ID: 7962458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE; Baulieu EE
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
    Nayak NR; Sengupta J; Ghosh D
    Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of progestin, glucocorticoid binding and glycogen content in rat endometrium before and after implantation: effect of antiprogesterone RU-38486].
    Takahashi T; Sakamoto H; Ohtani K; Suzuki H; Den K; Takagi S
    Nihon Naibunpi Gakkai Zasshi; 1988 Oct; 64(10):1081-7. PubMed ID: 3208917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical uses of antiprogestogens.
    Van Look PF; von Hertzen H
    Hum Reprod Update; 1995 Jan; 1(1):19-34. PubMed ID: 9080204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin production by the early pregnant guinea-pig uterus in relation to implantation and luteal maintenance, and the effect of oestradiol.
    Poyser NL
    J Reprod Fertil; 1984 Sep; 72(1):117-27. PubMed ID: 6590850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.